Glaukos Corporation
Status: Publicly traded
Direct answer
Glaukos Corporation is publicly traded on NYSE under the ticker GKOS.
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat...
Can you invest in Glaukos Corporation?
Yes. Glaukos Corporation is publicly traded on NYSE under the ticker GKOS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Glaukos Corporation
Detailed equity research is provided by MarketSnap.